Weekly recap

Insider trades and Congress trades, week of Feb 2–8, 2026

In the week of Feb 2–8, 2026, insiders filed 114 open-market purchases worth about $57.1M and 1,094 open-market sales; the largest purchase was $16.1M of W. R. Berkley Corporation (WRB) by MITSUI SUMITOMO INSURANCE CO LTD; members of Congress disclosed 34 purchases and 36 sales; 10 purchases stood out against the company's record since 2006.

By filing date, Monday to Sunday. Every line links to its SEC, House or Senate record. Public filings, not investment advice.

Purchases that stand out against 20 years of filings

Measured against every open-market trade the company's insiders filed since 2006. See all of them on the rare insider trades page.

Largest insider purchases

Largest insider sales

Congress trades disclosed

Members report a value range, not an exact amount; the trade can be up to 45 days older than its report.

Executives who announced they are leaving

  • Independence Realty Trust (IRT) · Feb 6, 2026

    “As previously disclosed in the Current Report on Form 8-K filed by Independence Realty Trust, Inc. (the "Company") with the Securities and Exchange Commission on December 8, 2025, Michele Weisbaum, the Company's Executive Vice President, General Counsel and Secretary, will retire from employment with the Company on or about March 31, 2026.” 8-K

  • Tempest Therapeutics (TPST) · Feb 6, 2026

    “On February 3, 2026, immediately following the closing of the Asset Acquisition (the “ Closing ”), Geoff Nichol resigned from the Board, effective immediately. Mr. Nichol’s resignation was not because of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.” 8-K

  • Acadia Realty Trust (AKR) · Feb 6, 2026

    “On February 3, 2026, Joseph Napolitano notified Acadia Realty Trust (the “Company”) of his intention to retire as Senior Vice President and Chief Administrative Officer of the Company, effective on or about April 1, 2026.” 8-K

  • Arcadia Biosciences (RKDA) · Feb 6, 2026

    “On February 4, 2026, each of Albert D. Bolles, Ph.D., a director and member of the Compensation Committee of the board of directors (the "Board") of Arcadia Biosciences, Inc. (the "Company"), and Deborah Carosella, a director and member of the Compensation Committee and Nominating and Governance Committee of the Board, notified the Company that effective as of February 4, 2026, such person was resigning as a…” 8-K

  • Renovorx (RNXT) · Feb 6, 2026

    “On February 3, 2026, Ronald B. Kocak notified the board of directors (the “Board”) of RenovoRx, Inc., a Delaware corporation (the “Company”), his intent to resign from his position as Principal Accounting Officer of the Company, effective as of the close of business on February 3, 2026.” 8-K

  • Olenox Industries (OLOX) · Feb 6, 2026

    “On January 31, 2026, Christoper Melton, a member of the Board of Directors (the “Board”) of Olenox Industries Inc. f/k/a Safe & Green Holdings Corp. (the “Company”), notified the Company of his decision to resign, effective January 31, 2026, from his position as a member of the Board and as a member of the following Board committees: the Audit Committee; the Executive Committee; and the Nominating, Environmental,…” 8-K

  • Hycroft Mining Holding (HYMC) · Feb 6, 2026

    “On February 5, 2026, Stephen A. Lang notified the board of directors (the “Board”) of Hycroft Mining Holding Corporation (the “Company”) of his decision to not stand for reelection to the Board at the Company’s 2026 annual meeting of stockholders (the “2026 Annual Meeting”) due to health reasons.” 8-K

  • Xcf Global (SAFX) · Feb 6, 2026

    “On February 2, 2026, XCF Global, Inc., a Delaware corporation (“ XCF ” or the “ Company ”), terminated the employment of Gregory Surette, Chief Strategy Officer.” 8-K

The company's own words, from the opening sentence of its Form 8-K (Item 5.02).

5% stakes filed (Schedules 13D and 13G)

Largest federal contract awards

See the record behind any of these

Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.

Get OQRO ProOpen Promis Neurosciences free$9.99 a month, cancel anytime